JPMorgan Downgrades Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) to Neutral Jun 3, 2026 09:24AM
Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) PT Lowered to JPY3,590 at TD Cowen Mar 27, 2026 10:07AM
UBS Starts Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) at Neutral Jan 26, 2026 05:18AM
Daiichi Sankyo opens Toronto headquarters to fuel Canadian oncology growth Jan 21, 2026 01:33PM
ENHERTU plus pertuzumab approved for first-line HER2+ metastatic breast cancer Dec 15, 2025 02:30PM


Jun 2, 2025 08:06AM Daiichi Sankyo, AstraZeneca (AZN): ENHERTU Plus Pertuzumab Reduced the Risk of Disease Progression or Death
May 19, 2025 07:01AM IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Certain Patients with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Apr 25, 2025 02:59AM Citi Reiterates Buy Rating on Daiichi Sankyo Company, Limited (4568:JP) (DSNKY)
Jan 7, 2025 11:00AM TD Cowen on Pharma: '10 Events in 2025 That Could Change Practice, Alter Companies, Move Stocks'
Sep 27, 2024 08:21AM Bernstein SocGen Group Reiterates Outperform Rating on Daiichi Sankyo Company, Limited (4568:JP) (DSNKY)
Sep 10, 2024 08:26AM TD Cowen Reiterates Buy Rating on Daiichi Sankyo Company, Limited (4568:JP) (DSNKY)
Sep 4, 2024 09:30AM Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) PT Raised to JPY7,600 at Jefferies
Aug 28, 2024 12:50AM Jefferies Reiterates Buy Rating on Daiichi Sankyo Company, Limited (4568:JP) (DSNKY)
Jul 10, 2024 07:25AM TD Cowen Starts Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) at Buy